Safety study of LBL-047 in healthy adults and lupus patients
Part of Immune system & allergy, Skin clinical trials.
This study tests a new drug called LBL-047 in healthy people and in people with mild to moderate lupus. It helps check if the drug is safe and how the body processes it. Participating may help find better treatments for lupus.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- You need to have either mild to moderate lupus or be a healthy volunteer (depending on the part of the study).
- If you can become pregnant or get someone pregnant, you must agree to use effective birth control during the study and for 6 months after.
- You must not have had an organ transplant or a stem cell transplant.
- You must not have a chronic infection (like certain fungal, viral, or bacterial infections).
- You must not have had major surgery within the last 90 days.
- You must not have a large tattoo or scar at the injection site.
- You must not have a fear of needles or blood that would make it hard to have blood drawn.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment, UB-VV410, for people with active systemic lupus erythematosus (SLE) or lupus nephritis (kidney inflammation caused by lupus) that hasn't responded to standard treatments. It aims to see if this therapy can help control the disease.
This study tests an experimental drug called GSK4527363. It is first being given to healthy volunteers to check safety, then to people with lupus (SLE) and people with connective tissue disease-related lung disease (CTD-ILD). The goal is to see if the drug is safe and how the body processes it.
This trial tests a new drug called SHR-2173 for people with active lupus. It aims to see if it can reduce disease activity when taken with standard treatments.
This trial tests an investigational injection called CM313 for people with active lupus (systemic lupus erythematosus). It aims to see if the drug can help reduce lupus symptoms and control the disease.
This study tests an experimental daily pill (BI 3000202) for people with active lupus (SLE) to see if it can reduce disease activity. It compares different doses against a placebo, and you must already be on stable lupus background treatment.
This trial tests a new experimental drug called ACT100 in healthy people to see if it is safe and how it works in the body. It is an early study, so it is not testing whether the drug helps treat a disease yet.
Hear when a new Systemic Lupus Erythematosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.